BAX Baxter International Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BAX

Price (delayed)

$35.51

Market cap

$18.1B

P/E Ratio

6.79

Dividend/share

$1.16

EPS

$5.23

Enterprise value

$29.24B

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating ...

Highlights
Baxter International's debt has decreased by 16% YoY
The revenue is up by 3% year-on-year
The company's equity rose by 39% YoY but it fell by 2.7% QoQ
The quick ratio is down by 3.3% since the previous quarter and by 2.2% year-on-year
The gross margin is down by 2.6% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.baxter.com
Peers: CAH BSX SYK BDX

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
509.58M
Market cap
$18.1B
Enterprise value
$29.24B
Valuations
Price to earnings (P/E)
6.79
Price to book (P/B)
2.21
Price to sales (P/S)
1.21
EV/EBIT
9.49
EV/EBITDA
6.71
EV/Sales
1.96
Earnings
Revenue
$14.89B
EBIT
$3.08B
EBITDA
$4.36B
Free cash flow
$708M
Per share
EPS
$5.23
Free cash flow per share
$1.39
Book value per share
$16.09
Revenue per share
$29.31
TBVPS
$30.42
Balance sheet
Total assets
$27.79B
Total liabilities
$19.55B
Debt
$14.17B
Equity
$8.17B
Working capital
$3.04B
Liquidity
Debt to equity
1.73
Current ratio
1.48
Quick ratio
0.87
Net debt/EBITDA
2.56
Margins
EBITDA margin
29.3%
Gross margin
34.2%
Net margin
17.8%
Operating margin
3%
Efficiency
Return on assets
9.2%
Return on equity
35%
Return on invested capital
14%
Return on capital employed
14.4%
Return on sales
20.7%
Dividend
Dividend yield
3.27%
DPS
$1.16
Payout ratio
22.2%

BAX stock price

How has the Baxter International stock price performed over time
Intraday
1.2%
1 week
0.45%
1 month
4.75%
1 year
-27.46%
YTD
-8.15%
QTD
6.16%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$14.89B
Gross profit
$5.09B
Operating income
$448M
Net income
$2.65B
Gross margin
34.2%
Net margin
17.8%
Baxter International's operating income has soared by 120% YoY and by 15% from the previous quarter
The operating margin has soared by 120% YoY and by 15% from the previous quarter
The revenue is up by 3% year-on-year
The gross margin is down by 2.6% year-on-year

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
BAX P/E details
P/E
6.79
P/B
2.21
P/S
1.21
EV/EBIT
9.49
EV/EBITDA
6.71
EV/Sales
1.96
BAX's P/B is 50% below its 5-year quarterly average of 4.4 and 25% below its last 4 quarters average of 2.9
The company's equity rose by 39% YoY but it fell by 2.7% QoQ
BAX's P/S is 56% below its 5-year quarterly average of 2.7 and 14% below its last 4 quarters average of 1.4
The revenue is up by 3% year-on-year

Efficiency

How efficient is Baxter International business performance
The company's return on equity has surged by 193% YoY but it fell by 8% QoQ
The ROIC has increased by 6% from the previous quarter

Dividends

What is BAX's dividend history
Dividend details
DPS
$1.16
Dividend yield
3.27%
Payout ratio
22.2%
Recent dividends

Financial health

How did Baxter International financials performed over time
The total assets is 42% more than the total liabilities
The total liabilities has decreased by 13% YoY
The current ratio fell by 13% YoY
Baxter International's debt is 73% more than its equity
The debt to equity has declined by 40% year-on-year but it has increased by 2.4% since the previous quarter
The company's equity rose by 39% YoY but it fell by 2.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.